Member Info for GeneralOz

Joe Rogan wouldn't want to interview Smiffy. He'd limit the interview to 30 minutes, tell him what questions to ask and tell him to ramp the stock.

It's a shame the master of death spirals, heights, don't see any value in the IP. They'd be keeping the shares instead of selling them if so.

It'll be listing on nasdaq at a substantially lower market cap than aim. Oh wait, it wouldn't even meet the entry requirements, regulations or compliance for nasdaq. Did the BOD really believe that hiring some potty mouthed american CEO was going to convince the idiots that they were going to list on nasdaq?

If you stick your money into premium bonds or a savings account it goes in the opposite direction to a death spiral.

More delay means more death spiral financing.

P1a still ongoing and P1b about to start. CC toned it down, the difference in her attitude and her predecessor is like a gaping chasm. Disastrous for LTHs.

Be careful what you wish for...

Need of funding not backed up by value inflection points drives the share price down to zero. This is what we’re seeing here and this is why GSA will keep doubling down.

The CLN and retail speculation makes this company the perfect target for shorts.

If this TW person wasn’t to be taken seriously, there’d have been less vitriol and abuse aimed at him. It seems his opinion leaves many on here rather unsettled.

Avacta, Novacyt and Roquefort - 3 sells, at least 2 zeros

They could have sold a few million LFTs

They could have got rid of the CEO before he did the dodgy CLN deal

They could have raised cash up at 100p

According to the chairman, 9 months ago he said we were 1 year away from those US specialist investors looking in. It seems like those specialist investors simply aren’t interested.

Maybe they’re waiting for the CLN to be paid off? Or maybe they want a therapeutics pure play instead?

This sub-study represents an ongoing collaboration between Avacta and SOFIE, in the use of [18F]FAPI-74 PET as a complementary diagnostic. [18F]FAPI-74 PET is currently in clinical development and for investigational use only.

So why is this company putting resources towards an additional and unnecessary partnership when they have a platform that needs to be proven through a course of clinical trials? It implies a lack of focus on what’s supposed to be the real deal and suggests that the BOD is trying to steer the ship away from being a therapeutics pure play.

It also implies that they’re aware that AVA6000 has a higher chance of failure than previously thought.

Small committed group of great people

Under Alastair Smith this company was by no means small. Is CC saying that the company has got smaller?

Seems like there’s been a change in strategy of this company. They’ve pivoted from being a therapeutics pure play to focusing on diagnostics. This could imply that the therapeutics program isn’t going as planned. Preparing for failure of AVA6000?

Well Tudor, it would appear that none of those buzzwords are applicable or accurate.

The trajectory of the LFT and the poor communication from the company during the development shares many parallels with the ongoing trial.

Could it be true that the outgoing CEO lied to investors? That the technology doesn’t work? That the trial is a failure?

Would you fire a CEO a few weeks or months away from a TO?

The answer is no. It can be said, with certainty, that there will be no TO for the foreseeable future. It's safe to assume that no TO talks have even begun. Plus, any prospective buyers will be scratching their heads and trying to figure out why the incompetant BOD didn't remove the CEO sooner.

The Wetherby site will soon be on the market. It’ll go faster than the LFT did, that’s for sure.

The real question everyone should be asking, is did Alastair Smith leave so he could dump his tiny amount of shares onto the market?

Who’d buy, what is now a loss making business?

It’ll be Avacta having to pay another company to take it off them at this rate. The whole thing has been a complete disaster of the highest order. CEO only stepped down once the damage was done.

Oh no. Here comes more dilution via the CLN. 20p placing anyone?

Who could possibly own the bond? Is it owned by Heights? Or by one of their clients?